Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
04/2011
04/21/2011US20110092691 Method For Filtering Nucleic Acids, In Particular From Fixed Tissue
04/21/2011US20110092690 Linker and support for solid phase synthesis of nucleic acid
04/21/2011US20110092689 Fluorescence quencher molecules
04/21/2011US20110092688 NUCLEIC ACID CONSTRUCT CONTAINING A NUCLEIC ACID DERIVED FROM THE GENOME OF HEPATITIS C VIRUS (HCV) OF GENOTYPE 2a, AND A CELL HAVING SUCH NUCLEIC ACID CONSTRUCT INTRODUCED THEREIN
04/21/2011US20110092686 Multicapillary sample preparation devices and methods for processing analytes
04/21/2011US20110092685 Amidite for synthesizing modified nucleic acid and method for synthesizing modified nucleic acid
04/21/2011US20110092679 Dark Quenchers For Donor-Acceptor Energy Transfer
04/21/2011US20110092575 Sirna of human osteopontin
04/21/2011US20110092574 mRNA Cap Analogs
04/21/2011US20110092572 Modulation of growth hormone receptor expression and insulin-like growth factor expression
04/21/2011US20110092571 Compositions and methods for sirna inhibition of icam-1
04/21/2011US20110092570 Oligomeric compounds comprising tricyclic nucelosides and methods for their use
04/21/2011US20110092568 Modulation of mlck-l expression and uses thereof
04/21/2011US20110092567 Cannabinoid 2 (Cb2) Receptor Gene Promoter and Unique RNA Transcripts in B Cells and Methods of Use
04/21/2011US20110092565 Method of treating neurodegenerative disease
04/21/2011US20110092441 Cell-permeable endostatin recombinant protein, a polynucleotide encoding the same, and an anti-cancer preparation containing the same as an active component
04/21/2011US20110092424 Production of glucagon like peptide 2 and analogs
04/21/2011US20110092422 Elastin based growth factor delivery platform for wound healing and regeneration
04/21/2011US20110092417 Leptin fusion proteins
04/21/2011US20110092409 Variants of a family 44 xyloglucanase
04/21/2011US20110092391 Phage lambda display constructs
04/21/2011US20110092388 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
04/21/2011US20110092382 Modified Nucleic Acid Probes
04/21/2011US20110092375 Deducing Exon Connectivity by RNA-Templated DNA Ligation/Sequencing
04/21/2011US20110091976 Regulatory region preferentially expressing to seed embryo and method of using same
04/21/2011US20110091975 Down-regulation of gene expression using artificial micrornas
04/21/2011US20110091969 Mutations in the ns5b protein of the hcv
04/21/2011US20110091959 Multiply-Substituted Protease Variants
04/21/2011US20110091958 Multiply-Substituted Protease Variants
04/21/2011US20110091952 Method for enzymatic production of decarboxylated polyketides and fatty acids
04/21/2011US20110091939 Methods and Compositions for Removing Specific Target Nucleic Acids
04/21/2011US20110091934 Laccase Variants
04/21/2011US20110091921 Novel 12 alpha-hydroxysteroid dehydrogenases, production and use thereof
04/21/2011US20110091898 Detection probe
04/21/2011US20110091894 Oligonucleotides for amplifying chlamydophila pneumoniae nucleic acid
04/21/2011US20110091892 Methods for the Diagnosis and Treatment of Lung Cancer
04/21/2011US20110091887 Method for detection of methylcytosine using photoresponsive probe
04/21/2011US20110091881 Mycobacterial genes down-regulated during latency
04/21/2011US20110091878 Dairy cattle breeding for improved milk production traits in cattle
04/21/2011US20110091876 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use
04/21/2011US20110091874 Ultrasensitive detection of target using target-ready particles
04/21/2011US20110091868 Novel antigen constructs useful in the detection and differentiation of antibodies to hiv
04/21/2011US20110091866 Detection of polyomavirus
04/21/2011US20110091526 Parasite Vaccine
04/21/2011US20110091502 Human parvovirus: humink parvovirus
04/21/2011US20110091501 Recombinant Rhinovirus Vectors
04/21/2011US20110091498 Methods of stimulating an immune response against prostate specific antigen
04/21/2011US20110091496 Methods and compositions for the delivery of vaccines to disrupted epithelium
04/21/2011US20110091494 Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto
04/21/2011US20110091492 Escherichia coli immunogens with improved solubility
04/21/2011US20110091491 Hiv-1 gp41 neutralization domain and use thereof
04/21/2011US20110091483 Canine Anti-CD20 Antibodies
04/21/2011US20110091480 Antigen-Binding Proteins Targeting S. Aureus Orf0657n
04/21/2011US20110091476 Human Anti-NGF Neutralizing Antibodies as Selective NGF Pathway Inhibitors
04/21/2011US20110091469 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof
04/21/2011US20110091467 Compositions and methods for modulating dopamine neurotransmission
04/21/2011US20110091460 Receptor-targeting reagents
04/21/2011US20110091449 Isolation of Anti-Desmoglein 1 Antibodies by Phage Display of Pemphigus Foliaceus Autoantibodies
04/21/2011US20110091441 Meganuclease variants cleaving a dna target sequence from the human interleukin-2 receptor gamma chain gene and uses thereof
04/21/2011US20110091417 Interleukin-22 Polypeptides, Nucleic Acids Encoding The Same And Methods For The Treatment Of Pancreatic Disorders
04/21/2011US20110091416 Immunoglobulin fusion proteins
04/21/2011US20110091412 Mutant interleukin-2 (il-2) polypeptides
04/21/2011US20110091377 Biomarkers for melanoma
04/21/2011US20110091372 Dual Variable Domain Immunoglobulins and Uses Thereof
04/21/2011US20110089944 Nucleic acid nanotube liquid crystals and use for nmr structure determination of membrane proteins
04/21/2011US20110088312 Biodiesel production method
04/21/2011CA2780741A1 Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro
04/21/2011CA2777835A1 Supercoiled minicircle dna for gene therapy applications
04/21/2011CA2777699A1 Phospholipases, nucleic acids encoding them and methods for making and using them
04/21/2011CA2777369A1 Quantification of ir-a and ir-b for tumor classification
04/20/2011EP2312024A1 Polymorphisms predictive of anthracycline-induced cardiotoxicity
04/20/2011EP2311994A1 Compositions and methods for preparing short RNA molecules and other nucleic acids
04/20/2011EP2311993A2 Method of detecting and quantifying hepatitis C virus
04/20/2011EP2311992A1 Method for rapid detection and identification of bioagents
04/20/2011EP2311973A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
04/20/2011EP2311965A1 Glutamine-rich maize seed protein and promoter
04/20/2011EP2311944A1 Polypeptides and polynucleotides from coagulase-negative staphylococci
04/20/2011EP2311848A1 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection
04/20/2011EP2311786A2 Methods for synthesis of encoded libraries
04/20/2011EP2310054A2 Aptamer inhibition of thrombus formation
04/20/2011EP1625142B1 Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein
04/20/2011CN1628179B Detection of hepatocellular carcinoma
04/20/2011CN102021243A Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores
04/20/2011CN102020813A Porous resin bead and method for producing nucleic acid using the same
04/20/2011CN102020812A Porous resin bead and method for producing nucleic acid using the same
04/20/2011CN101434630B Method for extracting mushroom genome
04/19/2011US7928298 Tomatoes having reduced polygalacturonase activity caused by non-transgenic mutations in the polygalacturonase gene
04/19/2011US7928294 Fatty acid desaturase for generating pinolenic and/or coniferonic acids in transgenic plants
04/19/2011US7928293 Expression vector comprising nucleotide sequences coding glutelin B gene regulatory sequences for transfer and expression heterologous genes in plant cells
04/19/2011US7928290 Viral capsid fusion peptide expressing plant cells
04/19/2011US7928220 for treating ocular disease, cancer and proliferative diseases and any other disease, condition, trait or indication that can respond to the level of SDF-1 in a cell or tissue
04/19/2011US7928219 chemically modified nucleic acid molecule; cancer; carcinoma, neovascularization, diabetic retinopathy, neovascular glaucoma, myopic degeneration and other proliferative diseases, restenosis and polycystic kidney disease
04/19/2011US7928218 Treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability
04/19/2011US7928217 Drug delivery of nucleotide into tumor; antitumor biodrugs; stability in cells; prevent gene expression of target genes
04/19/2011US7928216 Nuclease resistant external guide sequences for treating inflammatory and viral related respiratory diseases
04/19/2011US7928215 Methods of screening for compounds that inhibit the biosynthesis of GPI in malaria parasites
04/19/2011US7928214 P-cadherin antibodies
04/19/2011US7928212 Gene upregulated in cancers of the prostate
04/19/2011US7928211 Method for preparing compounds by nucleic acid directed synthesis
04/19/2011US7928210 Nucleoside based proliferation imaging markers